<div id="readability-page-1"><div><p>The United States market has shown robust performance, climbing 3.4% in the last 7 days and rising 30% over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, growth companies with high insider ownership often attract attention as they may signal strong confidence from those closest to the business's operations and future prospects.</p><h3>Top 10 Growth Companies With High Insider Ownership In The United States</h3><div><table><tbody><tr><td><strong>Name</strong></td><td><strong>Insider Ownership</strong></td><td><strong>Earnings Growth</strong></td></tr><tr><td>Upstart Holdings (UPST)</td><td>13%</td><td>50.8%</td></tr><tr><td>Precigen (PGEN)</td><td>11.9%</td><td>68.4%</td></tr><tr><td>Karman Holdings (KRMN)</td><td>17.2%</td><td>53.2%</td></tr><tr><td>GBank Financial Holdings (GBFH)</td><td>27.3%</td><td>42.2%</td></tr><tr><td>Clene (CLNN)</td><td>13.2%</td><td>62.2%</td></tr><tr><td>Caledonia Mining (CMCL)</td><td>14.3%</td><td>28.4%</td></tr><tr><td>Better Home &amp; Finance Holding (BETR)</td><td>20.6%</td><td>97.4%</td></tr><tr><td>AST SpaceMobile (ASTS)</td><td>27.9%</td><td>109.4%</td></tr><tr><td>Astera Labs (ALAB)</td><td>10.3%</td><td>29.0%</td></tr><tr><td>AppLovin (APP)</td><td>27.3%</td><td>21.6%</td></tr></tbody></table></div><p>Click here to see the full list of 205 stocks from our Fast Growing US Companies With High Insider Ownership screener.</p><p>Below we spotlight a couple of our favorites from our exclusive screener.</p><h2>Coastal Financial (CCB)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Coastal Financial Corporation, with a market cap of $1.24 billion, operates as the bank holding company for Coastal Community Bank, offering a range of banking products and services to consumers and small to medium-sized businesses in the Puget Sound region of Washington.</p><p><strong>Operations:</strong> The company generates revenue through its CCBX segment ($244.47 million), Community Bank services ($86.96 million), and Treasury &amp; Administration activities ($17.61 million).</p><p><strong>Insider Ownership:</strong> 13.9%</p><p><strong>Earnings Growth Forecast:</strong> 44.2% p.a.</p><p>Coastal Financial is poised for robust growth, with earnings projected to rise 44.2% annually, outpacing the US market. Revenue growth is also expected to be strong at 36.2% per year. Despite trading below its estimated fair value and analyst price targets, insider activity has been moderate recently. The appointment of Jeffrey M. Chapman to the board enhances its expertise in digital transformation, potentially supporting future strategic initiatives as the company navigates evolving financial landscapes.</p><ul><li>Take a closer look at Coastal Financial's potential here in our earnings growth report.</li><li>The valuation report we've compiled suggests that Coastal Financial's current price could be quite moderate.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eadc16e9-a802-44b8-be0d-66b5b5b18f1b/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/eadc16e9-a802-44b8-be0d-66b5b5b18f1b/chart/earnings-and-revenue-growth"/><figcaption>CCB Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Clover Health Investments (CLOV)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Clover Health Investments, Corp. offers Medicare Advantage plans in the United States and has a market cap of approximately $1.01 billion.</p><p><strong>Operations:</strong> The company's revenue is primarily derived from its insurance segment, which generated $1.92 billion.</p><p><strong>Insider Ownership:</strong> 21.5%</p><p><strong>Earnings Growth Forecast:</strong> 77.5% p.a.</p><p>Clover Health Investments is advancing its interoperability capabilities through partnerships, enhancing patient data access. Despite a recent CFO transition, the company remains focused on growth with revenue projected to increase by 16% annually, surpassing market averages. However, recent financials show a net loss of US$85.55 million for 2025 and insider selling has been significant over three months. Analysts predict profitability within three years and potential stock price appreciation of 47.5%.</p><ul><li>Click here to discover the nuances of Clover Health Investments with our detailed analytical future growth report.</li><li>In light of our recent valuation report, it seems possible that Clover Health Investments is trading behind its estimated value.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b181a9f8-182e-48cc-b994-e8c063d4c75b/chart/ownership-breakdown"/><figcaption>CLOV Ownership Breakdown as at Apr 2026</figcaption></figure><h2>Warby Parker (WRBY)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Warby Parker Inc. operates as a retailer of eyewear products through both physical stores and an e-commerce platform in the United States and Canada, with a market cap of approximately $2.61 billion.</p><p><strong>Operations:</strong> The company's revenue is primarily generated from Holistic Vision Care, amounting to $871.91 million.</p><p><strong>Insider Ownership:</strong> 15.1%</p><p><strong>Earnings Growth Forecast:</strong> 61.8% p.a.</p><p>Warby Parker's insider ownership aligns with its growth trajectory, as the company transitions to profitability with 2025 net income of US$1.64 million. Despite recent insider selling, analysts forecast earnings growth of 61.8% annually, outpacing the market average. Revenue is expected to grow at 16.5% per year, supported by strategic leadership changes and innovation like AI glasses. The stock trades below fair value estimates and anticipates a potential price increase of 39.3%.</p><ul><li>Click to explore a detailed breakdown of our findings in Warby Parker's earnings growth report.</li><li>The analysis detailed in our Warby Parker valuation report hints at an deflated share price compared to its estimated value.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/451a246a-a01c-44df-9a64-033f9f258c8f/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/451a246a-a01c-44df-9a64-033f9f258c8f/chart/earnings-and-revenue-growth"/><figcaption>WRBY Earnings and Revenue Growth as at Apr 2026</figcaption></figure><h2>Turning Ideas Into Actions</h2><ul><li>Investigate our full lineup of 205 Fast Growing US Companies With High Insider Ownership right here.</li><li>Ready For A Different Approach? The end of cancer? These 31 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.      It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.      All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p><div><h3>Valuation is complex, but we're here to simplify it.</h3><p>Discover if Warby Parker might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><p>Access Free Analysis</p></div></div></div>

CLOV

WRBY

<p>The U.S. market has risen 3.4% in the past week and 30% over the last year, with projected earnings growth of 16% annually. Companies with high insider ownership, such as Coastal Financial, Clover Health, and Warby Parker, are highlighted for their strong growth potential. Coastal Financial is expected to grow earnings by 44.2% annually, while Clover Health forecasts 77.5% growth despite recent losses. Warby Parker anticipates 61.8% earnings growth as it transitions to profitability. All three companies are trading below their estimated fair values, indicating potential for stock price appreciation.</p>

Coastal Financial And 2 Other Growth Companies With Strong Insider Confidence